Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
Cytotoxic Therapies Market Forecast
Interactive Model
Published: June 2009
Pages: For full details, please email keithw@cmsinfo.com
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 0.00 Buy Now!
Research from: Datamonitor
Sector: Indication Areas
Introduction
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued growth. Coupled with the launch of several new brands, steady growth of the cytotoxics market will occur to 2018, at a CAGR of 3.1%.
Reasons to Purchase
*Quantify the performance of each of the marketed cytotoxic therapy cancer brands in the seven major markets over the period 2008 to 2018
*Acquire a detailed account of cytotoxic therapy cancer brand dynamics and the events that drive and limit their market growth
*Benchmark the cytotoxic therapy cancer brands against their generics and rest of class and align their 7MM performance with a rest of world snapshot
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued growth. Coupled with the launch of several new brands, steady growth of the cytotoxics market will occur to 2018, at a CAGR of 3.1%.
Reasons to Purchase
*Quantify the performance of each of the marketed cytotoxic therapy cancer brands in the seven major markets over the period 2008 to 2018
*Acquire a detailed account of cytotoxic therapy cancer brand dynamics and the events that drive and limit their market growth
*Benchmark the cytotoxic therapy cancer brands against their generics and rest of class and align their 7MM performance with a rest of world snapshot